Patents by Inventor Simon Warren

Simon Warren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220105286
    Abstract: The disclosure relates to a pressurized Metered Dose Inhaler-compatible tablet, i.e. one that is able to be dispersed or disintegrates within a liquid phase propellant, which is used in a pressurized Metered Dose Inhaler formulation containing at least one active pharmaceutical ingredient and one or more excipients.
    Type: Application
    Filed: December 16, 2021
    Publication date: April 7, 2022
    Inventors: Glyn Taylor, Simon Warren, Cuong Tran
  • Patent number: 11260185
    Abstract: The disclosure relates to a pressurized Metered Dose Inhaler-compatible tablet, i.e. one that is able to be dispersed or disintegrates within a liquid phase propellant, which is used in a pressurized Metered Dose Inhaler formulation containing at least one active pharmaceutical ingredient and one or more excipients.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: March 1, 2022
    Assignee: Cardiff Scintigraphics Limited
    Inventors: Glyn Taylor, Simon Warren, Cuong Tran
  • Publication number: 20180207375
    Abstract: The invention relates to a method for the manufacture of a pressurized Metered Dose Inhaler (pMDI) and components for use in the method, in particular, a pMDI compatible tablet (i.e. one that is able to be dispersed or disintegrates within a liquid phase, such as a propellant, used in a pMDI formulation) which contains at least one active pharmaceutical ingredient (API) and, potentially, one or more excipients.
    Type: Application
    Filed: March 26, 2018
    Publication date: July 26, 2018
    Inventors: Glyn Taylor, Simon Warren, Cuong Tran
  • Patent number: 9981092
    Abstract: The invention relates to a method for the manufacture of a pressurized Metered Dose Inhaler (pMDI) and components for use in said method, in particular, a pMDI compatible tablet (i.e. one that is able to be dispersed or disintegrates within a liquid phase, such as a propellant, used in a pMDI formulation) which contains at least one active pharmaceutical ingredient (API) and, optionally, one or more excipients.
    Type: Grant
    Filed: February 12, 2015
    Date of Patent: May 29, 2018
    Assignee: CARDIFF SCINTIGRAPHICS LIMITED
    Inventors: Glyn Taylor, Simon Warren, Cuong Tran
  • Publication number: 20160354564
    Abstract: The invention relates to a method for the manufacture of a pressurised Metered Dose Inhaler (pMDI) and components for use in said method, in particular, a pMDI compatible tablet (i.e. one that is able to be dispersed or disintegrates within a liquid phase, such as a propellant, used in a pMDI formulation) which contains at least one active pharmaceutical ingredient (API) and, optionally, one or more excipients.
    Type: Application
    Filed: February 12, 2015
    Publication date: December 8, 2016
    Inventors: Glyn Taylor, Simon Warren, Cuong Tran
  • Publication number: 20050249674
    Abstract: An aerosol composition comprising a propellant and a first particulate material comprising particles having a median aerodynamic diameter with the range 0.05 to 11 ?m, such as a medicament suitable for pulmonary inhalation, and a second particulate material comprising particles having a median volume diameter within the range 15 to 200 ?m. The presence of the second particulate material provides good suspension properties, particularly where the propellant is a hydrofluoro alkane.
    Type: Application
    Filed: September 23, 2003
    Publication date: November 10, 2005
    Inventors: Paul Dickinson, Simon Warren